COVID-19 and overdoses drove Colorado’s death rate in 2021
Axios on facebookAxios on twitterAxios on linkedinAxios on emailIllustration: Annelise Capossela/AxiosColorado recorded an uptick in deaths related to COVID-19 and...
Coronavirus
‘Paxlovid rebound’ raises questions over how long antiviral COVID treatment should last
President Biden testing positive for COVID-19 again days after completing a course of Paxlovid has raised the question of whether...
Covid still packs a punch — and likely will for some time, experts say
Our tussle with Covid-19 — after a harrowing introduction and then wave upon wave of infections — seems to have...
Germany announces new Covid measures for fall, expecting another wave of infections
German Health Minister Karl Lauterbach speaks during a news conference about the situation of the coronavirus disease (COVID 19) pandemic,...
What is BA.4.6? The CDC is tracking a new COVID ‘variant of concern’ that’s overtaking earlier Omicron strains in at least 4 U.S. states
New lineages of the Omicron COVID variant, like BA.4 and BA.5, are helping spark a wave of reinfections, as people...
Covid ‘first-timers’ are feeding surge, but with milder symptoms and fewer hospitalizations
Scott Scanlon Lynne Jakubowski has spent more than two years following the ebbs, flows and public health recommendations that have...
Universities urged to allow for Covid impact on poorer students’ A-levels
Universities urged to allow for Covid impact on poorer students’ A-levelsPandemic has compounded working-class applicants’ disadvantages as teachers fear growing...
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_asset/file/23921122/download.jpeg "Patients did DIY blood draws in a new vaccine study")
Patients did DIY blood draws in a new vaccine study
Here’s how a research study to test for antibodies might normally go: participants who sign up go to a medical...
Senate Democrats just proposed $21 billion in new COVID-19 funding — here are 3 healthcare stocks that could stand to gain
Senate Democrats just proposed $21 billion in new COVID-19 funding — here are 3 healthcare stocks that could stand to...
COVID-19 Can Rebound Even In People Who Haven’t Taken Paxlovid, Study Finds
Around a third of people with COVID-19 will experience a rebound of their symptoms, regardless of whether they’ve been treated...